New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)

Listen Now

Topics Covered

• Overview of Acute Lymphocytic/Lymphoblastic Leukemia (ALL) in Children
• Current Standard of Care, Including Chemotherapy & New Treatment Approaches
• Treatment of Recurrent ALL
• Targeted Treatment & Stem Cell Transplantation
• The Role of Clinical Trials in Childhood ALL
• Preventing & Managing Treatment Side Effects, Discomfort & Pain
• Follow-Up Exams
• Social & Emotional Issues During & After ALL Treatment
• Late & Long-Term Effects of ALL Treatment in Children
• Key Questions to Ask the Doctor & Health Care Team in Making Treatment Decisions
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of OpenNotes
• Questions to Ask Our Panel of Experts

Our Panel of Experts

Anna C. Muriel, MD

Chief, Division of Pediatric Psychosocial Oncology, Institute Physician, Dana-Farber Cancer Institute, Associate Professor of Psychiatry, Harvard Medical School

Gabriel A. Robbins, MD

Pediatric Hematologist-Oncologist, Medical Director, Stephen D. Hassenfeld Children’s Center for Cancer & Blood Disorders, Hassenfeld Children’s Hospital at NYU Langone, Clinical Assistant Professor, Department of Pediatrics, NYU Grossman School of Medicine

Kevin Radelet

Executive Director, Leukemia Research Foundation

Shannon Coon, MSW

Children’s Program Coordinator, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on January 09, 2024.